Precision nanomedicines for prostate cancer

Research output: Contribution to journalEditorialOtherpeer-review

Abstract

Over the past decade, advances in nanotechnology have enabled the production of nanomaterial-based therapeutics. These nanomaterials, with a submicrometer size and high surface area, when used to diagnose and treat disease are known as nanomedicines. Nanomedicine is an interdisciplinary field combining nanotechnology and pharmaceutical and biomedical science, which offers new possibilities for the design of targeted-delivery platforms for both diagnosis and therapy. In cancer research, this technology has the potential to revolutionize the way we manage the malignancy not only by how treatment is directed but also from a diagnosis and prognosis perspective. Such nanomedicines will allow focus on early detection of disease, combining therapies by loading multiple therapeutics into nanoscale-delivery systems, and improved tumor specificity by selective targeting and delivery.
Original languageEnglish
Pages (from-to)803-807
Number of pages5
JournalNanomedicine
Volume13
Issue number8
DOIs
Publication statusPublished - 1 Apr 2018

Keywords

  • Biomarkers
  • Nanomedicine
  • Nanotechnology
  • Precision medicine
  • Prostate cancer

Cite this

@article{1fb2e55b56b14001b4decb4980c7d2bd,
title = "Precision nanomedicines for prostate cancer",
abstract = "Over the past decade, advances in nanotechnology have enabled the production of nanomaterial-based therapeutics. These nanomaterials, with a submicrometer size and high surface area, when used to diagnose and treat disease are known as nanomedicines. Nanomedicine is an interdisciplinary field combining nanotechnology and pharmaceutical and biomedical science, which offers new possibilities for the design of targeted-delivery platforms for both diagnosis and therapy. In cancer research, this technology has the potential to revolutionize the way we manage the malignancy not only by how treatment is directed but also from a diagnosis and prognosis perspective. Such nanomedicines will allow focus on early detection of disease, combining therapies by loading multiple therapeutics into nanoscale-delivery systems, and improved tumor specificity by selective targeting and delivery.",
keywords = "Biomarkers, Nanomedicine, Nanotechnology, Precision medicine, Prostate cancer",
author = "Anna Cifuentes-Rius and Butler, {Lisa M.} and Voelcker, {Nicolas H.}",
year = "2018",
month = "4",
day = "1",
doi = "10.2217/nnm-2018-0034",
language = "English",
volume = "13",
pages = "803--807",
journal = "Nanomedicine",
issn = "1743-5889",
publisher = "Future Medicine",
number = "8",

}

Precision nanomedicines for prostate cancer. / Cifuentes-Rius, Anna; Butler, Lisa M.; Voelcker, Nicolas H.

In: Nanomedicine, Vol. 13, No. 8, 01.04.2018, p. 803-807.

Research output: Contribution to journalEditorialOtherpeer-review

TY - JOUR

T1 - Precision nanomedicines for prostate cancer

AU - Cifuentes-Rius, Anna

AU - Butler, Lisa M.

AU - Voelcker, Nicolas H.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Over the past decade, advances in nanotechnology have enabled the production of nanomaterial-based therapeutics. These nanomaterials, with a submicrometer size and high surface area, when used to diagnose and treat disease are known as nanomedicines. Nanomedicine is an interdisciplinary field combining nanotechnology and pharmaceutical and biomedical science, which offers new possibilities for the design of targeted-delivery platforms for both diagnosis and therapy. In cancer research, this technology has the potential to revolutionize the way we manage the malignancy not only by how treatment is directed but also from a diagnosis and prognosis perspective. Such nanomedicines will allow focus on early detection of disease, combining therapies by loading multiple therapeutics into nanoscale-delivery systems, and improved tumor specificity by selective targeting and delivery.

AB - Over the past decade, advances in nanotechnology have enabled the production of nanomaterial-based therapeutics. These nanomaterials, with a submicrometer size and high surface area, when used to diagnose and treat disease are known as nanomedicines. Nanomedicine is an interdisciplinary field combining nanotechnology and pharmaceutical and biomedical science, which offers new possibilities for the design of targeted-delivery platforms for both diagnosis and therapy. In cancer research, this technology has the potential to revolutionize the way we manage the malignancy not only by how treatment is directed but also from a diagnosis and prognosis perspective. Such nanomedicines will allow focus on early detection of disease, combining therapies by loading multiple therapeutics into nanoscale-delivery systems, and improved tumor specificity by selective targeting and delivery.

KW - Biomarkers

KW - Nanomedicine

KW - Nanotechnology

KW - Precision medicine

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=85047565666&partnerID=8YFLogxK

U2 - 10.2217/nnm-2018-0034

DO - 10.2217/nnm-2018-0034

M3 - Editorial

VL - 13

SP - 803

EP - 807

JO - Nanomedicine

JF - Nanomedicine

SN - 1743-5889

IS - 8

ER -